Annual report [Section 13 and 15(d), not S-K Item 405]

Equity (Details)

Equity (Details) - USD ($) $ / shares in Units, $ in Thousands				1 Months Ended	12 Months Ended
	Apr. 23, 2024	Jan. 01, 2023	Apr. 23, 2019	Aug. 31, 2020	Dec. 31, 2024	Dec. 31, 2023
Equity [Line Items]
Gross proceeds					$ 29,255	$ 14,612
Number of shares of common stock authorized (in Shares)					1,000,000,000	1,000,000,000
Granted options to purchase shares (in Shares)					154,000	2,402,000
Exercise price (in Dollars per share)					$ 5.47	$ 5.28
Options Term		8 years 10 months 6 days			7 years 14 days	8 years 8 months 12 days
Option fair value					$ 600	$ 9,000
Expected life					6 years	6 years
Expected volatility minimum					80.50%	79.00%
Expected volatility maximum					90.50%	81.60%
Expected dividends						0.00%
Options to purchase common shares (in Shares)					500,000	300,000
Price per share (in Dollars per share)			$ 11.55
Warrant [Member]
Equity [Line Items]
Compensation expense					$ 5	$ 6
Warrant expired term	5 years
Warrant expired price per share (in Dollars per share)	$ 15
Minimum [Member]
Equity [Line Items]
Discount rate					4.19%	3.50%
Maximum [Member]
Equity [Line Items]
Discount rate					4.45%	4.82%
Stock Options [Member]
Equity [Line Items]
Options Term					10 years	10 years
Vesting period					4 years
Unrecognized compensation expense					$ 9,100
Weighted average term					2 years 7 months 6 days
Compensation expense					$ 4,600	$ 3,200
Stock Options [Member] \| Minimum [Member]
Equity [Line Items]
Exercise price (in Dollars per share)					$ 7.2	$ 5
Vesting period						4 years
Stock Options [Member] \| Maximum [Member]
Equity [Line Items]
Exercise price (in Dollars per share)					$ 8.15	$ 11.6
Vesting period						4 years 2 months 12 days
2019 Amended and Restated Stock Plan [Member]
Equity [Line Items]
Number of shares of common stock authorized (in Shares)					9,333,333
Common Stock [Member]
Equity [Line Items]
Aggregate amount					$ 200,000
Base prospectus					$ 500,000
Shares of common stock sold (in Shares)					3,500,000	1,900,000
Gross proceeds					$ 29,900	$ 15,100
Net proceeds					$ 29,300	$ 14,600
Expired warrant (in Shares)	1,400,000		1,400,000
Warrant expired underwritten offering shares (in Shares)			1,400,000
Common Stock [Member] \| Stock Options [Member]
Equity [Line Items]
Granted options to purchase shares (in Shares)					200,000	2,400,000
RSUs [Member]
Equity [Line Items]
Weighted average term					7 months 6 days
Compensation expense					$ 600	$ 600
Fair value of RSUs					1,800
Unrecognized compensation					$ 400
Capital on Demand Sales Agreement [Member]
Equity [Line Items]
Aggregate amount				$ 200,000